Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Treasury Shares (2019 - 2026)

Sotera Health has reported Treasury Shares over the past 6 years, most recently at $17.0 million for Q4 2025.

  • For Q4 2025, Treasury Shares fell 27.4% year-over-year to $17.0 million; the TTM value through Dec 2025 reached $17.0 million, down 27.4%, while the annual FY2025 figure was $17.0 million, 27.4% down from the prior year.
  • Treasury Shares for Q4 2025 was $859652.0 at Sotera Health, down from $2.9 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $3.9 million in Q3 2022 and troughed at $135073.0 in Q3 2024.
  • A 5-year average of $2.0 million and a median of $2.0 million in 2021 define the central range for Treasury Shares.
  • Biggest five-year swings in Treasury Shares: fell 1.34% in 2021 and later fell 27.4% in 2025.
  • Year by year, Treasury Shares stood at $33.5 million in 2021, then decreased by 11.24% to $29.8 million in 2022, then dropped by 8.71% to $27.2 million in 2023, then fell by 13.79% to $23.4 million in 2024, then fell by 27.4% to $17.0 million in 2025.
  • Business Quant data shows Treasury Shares for SHC at $17.0 million in Q4 2025, $18.7 million in Q3 2025, and $19.0 million in Q2 2025.